UCSF

Tagged: HIV

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

New drug targeted for Kaposi’s sarcoma

A team of scientists from UCSF and colleagues have identified a new potential drug target for the herpes virus that causes Kaposi’s sarcoma. Their research reopens the possibility of using a class of drugs called protease inhibitors, against diseases ranging from cancer to Alzheimer's Disease. This research was published online in Nature Chemical Biology, July 26, 2009.

Clinical pharmacists specialize in AIDS

From the time the antiretroviral therapy AZT was introduced in the 1980s to treat AIDS, the drug demanded close patient monitoring to be effective. AZT had many side effects and strict requirements for how and when to take it. Misuse of the drug could lead to viral resistance.

Hanoi summit on pharmacists and AIDS

UCSF leaders in pharmacy, international health, and AIDS met with their Vietnamese peers in Hanoi this October to plan how Vietnam's pharmacy workforce can curtail the spread of HIV in Vietnam.

Pages